Overview
Chenyu Lin is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Lin has been practicing medicine for over 10 years and is rated as an Experienced provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Acute Lymphoblastic Leukemia (ALL), Systemic Capillary Leak Syndrome, Bone Marrow Transplant, and Stent Placement. Dr. Lin is currently accepting new patients.
His clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Graft Versus Host Disease (GvHD).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Of North Carolina At Chapel Hill
Jonathan Serody is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Serody is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Serody is currently accepting new patients.
Duke Health Integrated Practice Inc
Nelson Chao is an Oncologist and a Hematologist in Durham, North Carolina. Dr. Chao is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft. Dr. Chao is currently accepting new patients.
Duke Health Integrated Practice Inc
Stefanie Sarantopoulos is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Sarantopoulos is rated as a Distinguished provider by MediFind in the treatment of Graft Versus Host Disease (GvHD). Her top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Chronic B-Cell Leukemia (CBCL), and Bone Marrow Transplant. Dr. Sarantopoulos is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Chronic Graft Versus Host Disease (cGvHD)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- B-Cell LymphomaDr. Lin isExperienced. Learn about B-Cell Lymphoma.
- Bone Marrow TransplantDr. Lin isExperienced. Learn about Bone Marrow Transplant.
- Deep Vein ThrombosisDr. Lin isExperienced. Learn about Deep Vein Thrombosis.
- Graft Versus Host Disease (GvHD)Dr. Lin isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaDr. Lin isExperienced. Learn about Leukemia.